Garnier, N., Pollet, K., Fourcot, M., Caplan, M., Marot, G., Goutay, J., . . . Engelmann, I. (2022). Altered microRNA expression in severe COVID‐19: Potential prognostic and pathophysiological role. Clinical & Translational Medicine, 12(6), 1. https://doi.org/10.1002/ctm2.899
Chicago Style (17th ed.) CitationGarnier, Nathalie, et al. "Altered MicroRNA Expression in Severe COVID‐19: Potential Prognostic and Pathophysiological Role." Clinical & Translational Medicine 12, no. 6 (2022): 1. https://doi.org/10.1002/ctm2.899.
MLA (9th ed.) CitationGarnier, Nathalie, et al. "Altered MicroRNA Expression in Severe COVID‐19: Potential Prognostic and Pathophysiological Role." Clinical & Translational Medicine, vol. 12, no. 6, 2022, p. 1, https://doi.org/10.1002/ctm2.899.